Drug Shortage Report for APO-DICLO SR

Last updated on 2021-12-20 History
Report ID 149705
Drug Identification Number 02162814
Brand name APO-DICLO SR
Common or Proper name DICLO-SR
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DICLOFENAC SODIUM
Strength(s) 75MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-18
Estimated end date 2021-12-17
Actual end date 2021-12-17
Shortage status Resolved
Updated date 2021-12-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-12-20 French Compare
v3 2021-12-20 English Compare
v2 2021-11-22 French Compare
v1 2021-11-22 English Compare

Showing 1 to 4 of 4